Ritalin
Parents Caught in the Middle as FDA Committee Debates
FDA Hearings on Ritalin: Black Box Labeling Recommendation for ADHD Medications in Debate
On February 9, 2006, the FDA’s standing Drug Safety and Risk Management Advisory Committee was tasked for the morning to study ADHD medications to see if there was a link between the stimulant medications and an increased risk of sudden death or serious cardiovascular problems from taking the medications.
The FDA also tasked the Committed with considering ways of studying the drugs without putting patients at risk. Read more of the article...
Ritalin
Just the mention of the name "Ritalin" can cause a wide variety of emotional reactions among people.
Some love Ritalin, as they have seen it help a loved one, and will defend it forever. Read more of the article...
